Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Somatostatin as inflow modulator in liver transplantation
2008-008319-24Phase 2Completed
- Sponsor
- Ghent University Hospital
- Start
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Cirrhosis comparing Somatostatin with Placebo (2 arms). Primary endpoint: Patient systemic hemodynamics. Started Jan 2009; status: completed.
02
Drugs
somatostatin
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on 2008-008319-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008319-24.